These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36935311)
21. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice. Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656 [TBL] [Abstract][Full Text] [Related]
22. Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop. Bai XL; Yang XY; Li JY; Ye-Li ; Jia X; Xiong ZF; Wang YM; Jin S Oncotarget; 2017 Nov; 8(61):103985-103995. PubMed ID: 29262615 [TBL] [Abstract][Full Text] [Related]
23. C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells. Bian F; Yang X; Zhou F; Wu PH; Xing S; Xu G; Li W; Chi J; Ouyang C; Zhang Y; Xiong B; Li Y; Zheng T; Wu D; Chen X; Jin S Br J Pharmacol; 2014 May; 171(10):2671-84. PubMed ID: 24517733 [TBL] [Abstract][Full Text] [Related]
24. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319 [TBL] [Abstract][Full Text] [Related]
25. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439 [TBL] [Abstract][Full Text] [Related]
26. High glucose levels accelerate atherosclerosis via NLRP3-IL/ MAPK/NF-κB-related inflammation pathways. Sun H; Ma X; Ma H; Li S; Xia Y; Yao L; Wang Y; Pang X; Zhong J; Yao G; Liu X; Zhang M Biochem Biophys Res Commun; 2024 Apr; 704():149702. PubMed ID: 38422898 [TBL] [Abstract][Full Text] [Related]
27. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout. Dang WT; Xu D; Zhou JG Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615 [TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils. Fujita Y; Matsuoka N; Temmoku J; Furuya MY; Asano T; Sato S; Kobayashi H; Watanabe H; Suzuki E; Urano T; Kozuru H; Yatsuhashi H; Koga T; Kawakami A; Migita K Arthritis Res Ther; 2019 Nov; 21(1):250. PubMed ID: 31775905 [TBL] [Abstract][Full Text] [Related]
29. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970 [TBL] [Abstract][Full Text] [Related]
30. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A. Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273 [TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation. Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264 [TBL] [Abstract][Full Text] [Related]
32. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis. Yang L; Gao C Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593 [TBL] [Abstract][Full Text] [Related]
33. Non-canonical NF-κB contributes to endothelial pyroptosis and atherogenesis dependent on IRF-1. Fan X; Li Q; Wang Y; Zhang DM; Zhou J; Chen Q; Sheng L; Passerini AG; Sun C Transl Res; 2023 May; 255():1-13. PubMed ID: 36384204 [TBL] [Abstract][Full Text] [Related]
34. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE Yan J; Li M; Wang XD; Lu ZY; Ni XL Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379 [TBL] [Abstract][Full Text] [Related]
35. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation. Zhuang T; Liu J; Chen X; Zhang L; Pi J; Sun H; Li L; Bauer R; Wang H; Yu Z; Zhang Q; Tomlinson B; Chan P; Zheng X; Morrisey E; Liu Z; Reilly M; Zhang Y Circ Res; 2019 Aug; 125(6):590-605. PubMed ID: 31318658 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of Jiangzhi Xiaoban tablet on toll-like receptor 4/nuclear factor-kappa B/nod-like receptor protein 3 signaling pathway in mice with atherosclerosis induced by high-fat diet. Huihui L; Jun F; Jianhe L; Choufu C; Guoheng HU J Tradit Chin Med; 2024 Feb; 44(1):88-94. PubMed ID: 38213243 [TBL] [Abstract][Full Text] [Related]
37. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis. Guo S; Wang L; Cao K; Li Z; Song M; Huang S; Li Z; Wang C; Chen P; Wang Y; Dai X; Chen X; Fu X; Feng D; He J; Huo Y; Xu Y Cardiovasc Res; 2024 Jul; 120(8):883-898. PubMed ID: 38626254 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL. Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice. Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729 [TBL] [Abstract][Full Text] [Related]
40. Endothelial caveolin-1 plays a major role in the development of atherosclerosis. Pavlides S; Gutierrez-Pajares JL; Iturrieta J; Lisanti MP; Frank PG Cell Tissue Res; 2014 Apr; 356(1):147-57. PubMed ID: 24390341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]